Wenzel Spine announces acquisition of Statera Spine

1080

Wenzel Spine has announced that it has completed the acquisition of Statera Spine, a pre-operative diagnostics and quantitative data software solution that developed to aid treatment decisions for spine patients.

Statera Spine is a software enabled spine imaging analytics company dedicated to providing easy-to-use solutions that facilitate improved care for patients suffering from chronic and acute spine issues. Standard pre-operative imaging does not allow for consideration of overall spine biomechanics, including sagittal alignment. The ProfileESP (Expanded Spine Parameters Report), VMA (Vertebral Motion Analysis) technology and integrated Surgical Planning Solution will enhance Wenzel’s current spine fusion-related product portfolio by providing vital diagnostic and decision-making tools that are missing from today’s technology, the company said in a press release.

“Solutions in diagnostics and surgical planning tools play a critical role in the advancement of Wenzel Spine’s total solution offering in minimally invasive surgery,” said Chad Neely, CEO of Wenzel Spine. “We are very excited to have the experience, expertise and dedication of the Statera Spine team as part of Wenzel Spine. The addition of these unique diagnostic and planning solutions complement our existing minimally invasive implant technology and allow us to bring comprehensive solutions to spine surgeons and their patients. By combining diagnostics with our MIS implant portfolio, we can continue to advance minimally invasive spine surgery, while reducing overall cost.”

The new Wenzel Spine Diagnostics service offering will allow physicians to utilise full spine alignment data, plus motion (angulation and translation) and disc height data at each spine level to aid in the decision-making process alongside their patients, the company press release adds.

Profile ESP and VMA are commercially available in the USA. The Surgical Planning Solution is planned to be launched and commercially available in the USA in early 2021.


LEAVE A REPLY

Please enter your comment!
Please enter your name here